VJDementia is committed to improving our service to you

Share this video  

VJDementia is committed to improving our service to you

EAN 2020 | Post-COVID-19 dementia landscape

Paola Barbarino • 26 May 2020
EAN 2020
Alzheimer’s Disease Dementia
Care Practice COVID-19 Perspectives Policy

Paola Barbarino, CEO, Alzheimer’s Disease International, shares her perspective on what is to come in the Alzheimer’s disease space, particularly the impact of COVID-19 on the diagnosis of dementia and disruption in clinical trials. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Paola Barbarino

4:30
Alzheimer's disease: what are the challenges when disease-modifying therapies become available?
Paola Barbarino • 26 May 2020
4:20
Dementia care during the COVID-19 pandemic
Paola Barbarino • 26 May 2020
5:47
Is the world prepared for dementia?
Paola Barbarino • 26 May 2020

Related Videos

3:49
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials
Philip Tipton • 27 Apr 2023
1:19
Expanding research into biomarkers for RPD differentiation
Philip Tipton • 27 Apr 2023
4:01
Use of AD blood-based biomarkers for trial enrolment
Philip Tipton • 27 Apr 2023
5:36
Characterizing protein accumulation in primary vulnerable neurons in Alzheimer’s disease
Alessia Caramello • 25 Apr 2023
The content of VJDementia is intended for healthcare professionals